Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice DD..added ALXA shares and Dec call options. Thanks
thanks buddy !!
I am talking about EXEL ?..I have a order seating @ $1 to buy June 12 calls for EXEL
hey buddy..can I ask you at what price did you buy those calls ?
Hey man..what's your view on PCRX ?? they have PDUFA date of 7/28
Thanks,
TZ
Congrts to all XNPT holders
ok..thanks for that info !!
ARE YOU AN IDIOT ??
BIEL up 30% on the down day..nice volume coming in..
BIEL what a shake today...congrts to all who added today...
Thanks and pls let us know when you buy this...:)..GLTA
Hey buddy..whats your view on CLSN...it looks like pretty much at the bottom and last month they received positive comments from FDA about their new drug application for ThermoDox..
Thanks,
TZ
I have 5K shares of AVNR with an average of $2.90...wish I could have added more shares on friday when it dipped to $1.50...Tomorrow will be very exicting day for all the AVNR shares holders..short interest is around 12-15 million shares ...GLTA
AVNR FDA approval
It got FDA approval Friday evening and it;s the only FDA approved drug for the treatment of pseudobulbar affect (PBA)...Huge market for this drug and great chance for the buyout...Analyst have predicted stock price of $9 - $12 after FDA approval...
http://www.reuters.com/finance/stocks/keyDevelopments?rpc=66&symbol=AVNR.O×tamp=20101029221700
AVNR FDA approval
It got FDA approval Friday evening and it;s the only FDA approved drug for the treatment of pseudobulbar affect (PBA)...Huge market for this drug and great chance for the buyout...Analyst have predicted stock price of $9 - $12 after FDA approval...
http://www.reuters.com/finance/stocks/keyDevelopments?rpc=66&symbol=AVNR.O×tamp=20101029221700
AVNR for me buddy !!..
It got FDA approval Friday evening and it;s the only FDA approved drug for the treatment of pseudobulbar affect (PBA)...Huge market for this drug and great chance for the buyout...Analyst have predicted stock price of $9 - $12 after FDA approval...
http://www.reuters.com/finance/stocks/keyDevelopments?rpc=66&symbol=AVNR.O×tamp=20101029221700
AVNR will be easily $9 next week and well ablove $15 in next few months time..It;s the only FDA approved drug for the treatment of pseudobulbar affect (PBA)...huge market and huge potential for this stock in near future..IMO..
Congrts guys...it;s time to rock and roll !!
I am holding all shares thru weekend !!
Nice to see AVNR moving..long and strong here !! Added few more shares last week..Holding all my shares through FDA decison..GLTA
When is the results due ??
Short has to cover pretty soon..they are going to burn really bad here once AVNR gets the approval..IMO...most of the analyst have given target price of $9+..
AVNR lot of positive comments..I think it has a best chance to get the approval..will load more if I get anything under $3.10 ...GLTA
It looks like a bad day for BioTech stocks..Some stocks have reported positive data from the study and still down - ALTH , BPAX and OXGN all down.
ALTH ($4.57) Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of FOLOTYN(R) in Patients with Advanced Non-Small Cell Lung Cancer
http://www.marketwatch.com/story/allos-therapeutics-announces-presentation-of-favorable-survival-data-from-randomized-phase-2b-study-of-folotynr-in-patients-with-advanced-non-small-cell-lung-cancer-2010-10-11?reflink=MW_news_stmp
ALTH ($4.57) Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of FOLOTYN(R) in Patients with Advanced Non-Small Cell Lung Cancer
http://www.marketwatch.com/story/allos-therapeutics-announces-presentation-of-favorable-survival-data-from-randomized-phase-2b-study-of-folotynr-in-patients-with-advanced-non-small-cell-lung-cancer-2010-10-11?reflink=MW_news_stmp
Great call buddy !! ..you are the man !!..Anyone can easily make money by just following you...keep up the good work and have a great weekend !!
ALTH ($4.61)- phase II study of Folotyn versus Tarceva in non-small cell lung cancer on October 11.
Allos Therapeutics(ALTH_)
Drug: Folotyn
Indication: Non-small cell lung cancer
Presentation: Mon. Oct. 11
Full presentation of data from a phase II study of Folotyn versus Tarceva in non-small cell lung cancer. In July, Allos said preliminary results from the study demonstrated that Folotyn reduced the risk of death compared to Tarceva, although the results were not statistically significant. In patients with non-squamous cell lung cancer, which comprises the largest subgroup of lung cancer patients, Folotyn demonstrated a 35% reduction in the risk of death compared to Tarceva. This subgroup is important because it's where Astellas (formerly OSI Pharmaceuticals) generated the bulk of Tarceva's $1.2 billion in 2009 worldwide sales.
ALXA bought few shares @ 2.87 here..cant resist ..it looks like a discounted price..IMO..GLTA
ALXA ($3.19) nice close..Huge order 300K @ the last minute..
DVME - ready to move..CEO said more PRs to come this fall..load the cheapies...Next 10 bagger here..IMO
DVME ready for the breakout here..company is active and as per the CEO lot many PRs to come this fall..load them up @ .0001..might be next 10 bagger..IMO
DVME @ .0001 - load the cheapies guys..2 good news in last 4 days and lot many PRs to come this fall..This will be easily .0005 in 1 month time...IMO..GLTA
Great start..almost 25 million in the volume already...we need days with 100 - 200 million volume and we will start moving up ..this is just the start and lots of news to come..great price to load guys..IMO..GLTA
yupp lets work as a Team and post DVME on other active IHUB boards..
Agreed..We need volume..good thing is company is active and soon we will see more updates and PPS will move higher..
Smart thing is to load now..I have 25 million shares will continue loading more @ .0001 - Rewards are much higher than the risk here..
DVME @ .0001 - news out...string of PRs to come this fall..company is making a nice progress...More rewards than risk..could be easily next 10 bagger with some volume
Diverse Media Group, Inc.'s Talent Representation Agency Opens Print Division
DVME @ .0001 great news today and more to come this fall..Winner all the way if you load @ this level..Time to make some money ..GLTA
Great news today and more to come..DVME @ .0001 is a great play..we have a winner here guys..lets work as a Team..we need more volume and price will follow..Lets spread the news..GLTA